← FDA Drug Approvals (Drugs@FDA)

MICAFUNGIN

NDA · New Drug Application · Sponsor: PH HEALTH · Approved 2021-06-16

Drug application

FDA Application #

NDA212156

Application type

New Drug Application

Brand name

MICAFUNGIN

Generic name

MICAFUNGIN

Active ingredients

MICAFUNGIN SODIUM

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

PH HEALTH

Manufacturer

Par Health USA, LLC

First approval

2021-06-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown